A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Carma1-Bcl10-Malt1 signaling module bridges TCR signaling to the canonical IκB kinase (IKK)/NF-κB pathway. Covalent attachment of regulatory ubiquitin chains to Malt1 paracaspase directs TCR signaling to IKK activation. Further, the ubiquitin-editing enzyme A20 was recently suggested to suppress T cell activation, but molecular targets for A20 remain elusive. In this paper, we show that A20 regulates the strength and duration of the IKK/NF-κB response upon TCR/CD28 costimulation. By catalyzing the removal of K63-linked ubiquitin chains from Malt1, A20 prevents sustained interaction between ubiquitinated Malt1 and the IKK complex and thus serves as a negative regulator of inducible IKK activity. Upon T cell stimulation, A20 is rapidly removed and paracaspase activity of Malt1 has been suggested to cleave A20. Using antagonistic peptides or reconstitution of Malt1−/− T cells, we show that Malt1 paracaspase activity is required for A20 cleavage and optimal IL-2 production, but dispensable for initial IKK/NF-κB signaling in CD4+ T cells. However, proteasomal inhibition impairs A20 degradation and impedes TCR/CD28-induced IKK activation. Taken together, A20 functions as a Malt1 deubiquitinating enzyme and proteasomal degradation and de novo synthesis of A20 contributes to balance TCR/CD28-induced IKK/NF-κB signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBASH3A (rank 10), TNFAIP3, and its partner TNIP1 (rank 13 and 24, respectively) inhibit TCR-induced NFkB signaling, a critical survival and growth signal for activated CD8+ T cells (Düwel et al., 2009; Ge et al., 2017).”
From Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function (2018) · cites this paper as Düwel et al., 2009
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892 · cited 1×
“In T cells, activation of the atypical protein kinase C (PKC) has been shown to provide a critical link between TCR/ CD28 proximal signaling events and the NF- B pathway (4).”
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Newton, K., Matsumoto, M. L., Wertz, I. E., Kirkpatrick, D. S., Lill, J. R., Tan, J., Dugger, D., Gordon, N., Sidhu, S. S., Fellouse, F. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.039 · Cited by 555
Ruland, J., Duncan, G. S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D. G., Bouchard, D., Wakeham, A., Ohashi, P. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00189-1 · Cited by 553
Self-citationBcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434 · cited 8×
“Interestingly, two recent reports have shown that Malt1 paracaspase activity is required for optimal IL-2 production and it was suggested that the paracaspase-dependent cleavage of A20 could be one explanation for this result (28, 29).”
Self-citationRequirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429 · cited 1×
“In addition, association of PDK1 and Caspase8 to the PKC -CBM signaling module has been shown to facilitate TCR-induced NF- B activation (12, 13).”
Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling
Ruland, J., Duncan, G. S., Wakeham, A., & Mak, T. W. (2003) · Immunity · doi:10.1016/s1074-7613(03)00293-0 · Cited by 390
Self-citation
Cited by
Items 201–234 of 234
MALT1 Paracaspase: A Unique Protease Involved in B-Cell Lymphomagenesis
Vincendeau, M., Nagel, D., Eitelhuber, A. C., & Krappmann, D. (2013) · International Journal of Hematologic Oncology · doi:10.2217/ijh.13.45 · Cited by 2
Self-citationDetection of Recombinant and Cellular MALT1 Paracaspase Activity
Nagel, D., & Krappmann, D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2422-6_13 · Cited by 2
Self-citationGenetic convergence of rare lymphomas
Shingleton, J. R., & Davé, S. S. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000435 · Cited by 2
Pathogenesis of Gastric MALT Lymphoma
Kim, H. H., & Park, M. I. (2011) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2011.11.3.145 · Cited by 1
Dysregulated CARD11 signaling in the development of diffuse large B cell lymphoma
Jones, T. A., Hutcherson, S. M., Bedsaul-Fryer, J. R., & Pomerantz, J. L. (2020) · LymphoSign Journal · doi:10.14785/lymphosign-2020-0006 · Cited by 1
Borg, N. A., & Dixit, V. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.11007-0 · Cited by 2
TNFAIP3 (Tumor Necrosis Factor, Alpha-Induced Protein 3)
McElroy, R., Ennis, M., & Schock, B. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101957 · Cited by 1
Layzell, S., Barbarulo, A., & Seddon, B. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.558996 · Cited by 1
“Accelerated cell death of activated T cells lacking both IKK2 and A20 Following T cell activation, TCR induced TRAF activity targets A20 for degradation (Coornaert et al., 2008; Duwel et al., 2009).”
BackgroundFunctional Characterization of Porcine (Sus scrofa) BCL10
Mazzone, P., Scudiero, I., Ferravante, A., Paolucci, M., D’Andrea, L. E., Varricchio, E., Telesio, G., Pizzulo, M., Zotti, T., Reale, C., et al. (2015) · Open Journal of Immunology · doi:10.4236/oji.2015.52007
“As for hBCL10 [11] [25] [26], pBCL10-induced NF-kB activation requires ubiquitination(s) events, since NF-kB activation is completely abrogated following co-expression of A20 de-ubiquitinase (Figure 5(b)).”
BackgroundStrukturelle Analyse von Phenothiazin‐Derivaten als allosterische Inhibitoren der MALT1‐Paracaspase
Schlauderer, F., Lammens, K., Nagel, D., Vincendeau, M., Eitelhuber, A. C., Verhelst, S. H. L., Kling, D., Chruściel, A., Ruland, J., Krappmann, D., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201304290
Self-citationHeger, K.-D. (2014) · MPG.PuRe (Max Planck Society) · doi:10.5282/edoc.17240 · Cited by 1
Creation of a Retroviral RNAi Knockdown System to Investigate Gene Variants in SLE
Lifeso, K. (2013) · TSpace (University of Toronto)
Transcriptional regulation of the anti-inflammatory protein tristetraprolin (TTP)
Cunliffe, H. E. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Signaling Pathways in Rare Lymphomas
Lipsky, A. H., Pérez‐Galán, P., Agostinelli, C., Piccaluga, P. P., Pileri, S. A., & Wiestner, A. U. (2014) · Springer eBooks · doi:10.1007/978-3-642-39590-1_4
Mechanism of Ubiquitin Induced Activation of RIG-I Like Receptors in Antiviral Innate Immunity
Jiang, X. (2012) · Cited by 1
Role of Proteases in Tumor Immune Evasion
Panda, A. K., Chakraborty, S., Kajal, K., Roy, D., Sarkar, T., & Sa, G. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_12
Thome, M., & Hailfinger, S. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00513-5
Immune Homeostasis: Activation and Downregulation of NF-κB
De, A. (2015) · Springer theses · doi:10.1007/978-3-319-14965-3_1
TNFAIP3 (Tumor Necrosis Factor, Alpha-Induced Protein 3)
McElroy, R., Ennis, M., & Schock, B. C. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101957-1
MALT1(Mucosa-Associated Lymphoid Tissue Translocation Gene 1)
Gewies, A., & Ruland, J. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_234
Self-citationMALT1(Mucosa-Associated Lymphoid Tissue Translocation Gene 1)
Gewies, A., & Ruland, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_234
Self-citationKumar, A., Chawla, V., Chawla, P. A., Bhatia, N., Singh, M. P., & Singh, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00014-0 · Cited by 1
Regulation of NF-κB Signaling by Regulatory Ubiquitination: Specific Pathways and A20
De, A. (2015) · Springer theses · doi:10.1007/978-3-319-14965-3_2
Downregulation of A20 Expression Related to T Cells by Staphylococcal Enterotoxin A Treatment
Chen, X., Yan, Y., Lin, C., Yang, J., & Qiu, H. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06386-y
“It has been reported that A20 negatively regulated TCR-NF-κB by cleaving MALT1 ubiquitin chains [17].”
Soto‐Díaz, K., Varfolomeev, E. E., & Vucic, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00198-8
Scaffold and Adapter Molecules in Immune Receptor Signaling
Snow, A. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00160-5
Base-editing a single missense mutation in A20 enhances CAR-T cell efficacyPreprint
Blaisdell, A., Bachl, S., Sandoval, L. R., Ching, C., Bowman, C., Kale, N., Prabandham, M., Diolaiti, M. E., Havig, C. C., Advincula, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.05.680562 · Cited by 2
Hamilton, K. S. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Elucidating the Vulnerability of Glioblastoma Stem-like Cells to Lysosomal Dysfunctions
Maghe, C. (2023) · theses.fr (ABES) · doi:10.70675/cb5da8bdzc225z4cf1z80a7zeb24afa442f9
TNFAIP3 in M2 Macrophage Attenuates Subretinal Fibrosis in Laser-Induced Murine Model
Zhao, Q., Gong, Y., Zhang, L., Chen, C., Li, L., Ma, Z., Chen, F., Cai, S., Sovannkiri, N., Zhou, X., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.5.25
The requirement of MALT1 activity for the growth of adult T cell leukemia/lymphoma
Kamiunten, A., Morishita, D., Kameda, T., Sugiyama, M., Ebara, S., Kogure, Y., Mizutani, A., Hirayama, T., Kawamoto, T., Ochi, Y., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116850
“28,29 In addition, one MALT1 inhibitor (JNJ-67856633) is undergoing phase 1 clinical trials.”
The role of vitamin D signalling in β cell apoptosis: a systematic review
Li, D., Norris, N., An, Y., & Gunton, J. E. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02453-5
BindingDB Entry 50023713: MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies.
BindingDB (2026) · UC San Diego · doi:10.7270/q2s46xxp
Metadata
- Authors
- Düwel, M., Welteke, V., Oeckinghaus, A., Baens, M., Kloo, B., Ferch, U., Darnay, B. G., Ruland, J., Marynen, P., & Krappmann, D.
- Affiliations
- Helmholtz Munich (DE)
- Vlaams Instituut voor Biotechnologie (BE)
- TUM Klinikum (DE)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Welteke, Verena
- Oeckinghaus, Andrea
- Kloo, Bernhard
- Krappmann, Daniel
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 182
- Issue
- 12
- Pages
- 7718-7728
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1955888505
- Cited by
- 233
- References
- 40
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 8 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 12 · 2019: 10 · 2018: 16 · 2017: 13 · 2016: 18 · 2015: 21 · 2014: 17 · 2013: 20 · 2012: 15
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Silence Therapeutics
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- A20, MALT1, T cell receptor signaling, NF-κB, IKK activation, K63-linked ubiquitin, deubiquitination, paracaspase, CD28 costimulation, proteasomal degradation, IL-2 production, T cell activation
- MeSH terms
- Tumor Necrosis Factor alpha-Induced Protein 3, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Cell Line, DNA-Binding Proteins, Enzyme Activation, Humans, Neoplasm Proteins, Nuclear Proteins, Protein Binding, Receptors, Antigen, T-Cell, Signal Transduction, Down-Regulation, NF-kappa B, Caspases, Ubiquitin, RNA, Small Interfering, Proteasome Endopeptidase Complex, Intracellular Signaling Peptides and Proteins, I-kappa B Kinase, CARD Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.